Cargando…
Emodin Inhibited Pathological Cardiac Hypertrophy in Response to Angiotensin-Induced Hypertension and Altered the Gut Microbiome
Objective: Evidence suggests that food bioactives affect the epigenome to prevent pathological cardiac hypertrophy. Recently, we showed that emodin, an anthraquinone, attenuated pathological cardiac hypertrophy and histone deacetylase (HDAC) activity. However, we only examined the cardioprotective e...
Autores principales: | Evans, Levi, Price, Tori, Hubert, Nathaniel, Moore, Julia, Shen, Yiqui, Athukorala, Maheshi, Frese, Steven, Martinez-Guryn, Kristina, Ferguson, Bradley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526847/ https://www.ncbi.nlm.nih.gov/pubmed/37759673 http://dx.doi.org/10.3390/biom13091274 |
Ejemplares similares
-
The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases
por: Evans, Levi W., et al.
Publicado: (2020) -
Divergent and Overlapping Roles for Selected Phytochemicals in the Regulation of Pathological Cardiac Hypertrophy
por: Evans, Levi, et al.
Publicado: (2021) -
The microbiome of an outpatient rehabilitation clinic and predictors of contamination: A pilot study
por: Brigando, Gabriella, et al.
Publicado: (2023) -
Selective Regional Alteration of the Gut Microbiota by Diet and Antibiotics
por: Poteres, Elesa, et al.
Publicado: (2020) -
Minimizing confounders and increasing data quality in murine models for studies of the gut microbiome
por: Miyoshi, Jun, et al.
Publicado: (2018)